Dr. Jimmie Holland on the Evolution of Genomic Medicine in Oncology

December 3, 2015
Jimmie Holland

Jimmie Holland, MD, Wayne E. Chapman Chair in Psychiatric Oncology, Memorial Sloan Kettering Cancer Center, on the development of genomic medicine in oncology.

Jimmie Holland, MD, Wayne E. Chapman Chair in Psychiatric Oncology, Memorial Sloan Kettering Cancer Center, explains the development of genomic medicine in oncology. Holland says that as the field progresses and we learn about the biological makeup of tumors, oncologists can targeted specific aspects of different cancers. She adds that researchers are also finding different links between certain cancers, as well as discovering new subtypes of cancers that can lead to different, yet effective, treatments methods.

Holland adds that while genomic medicine is becoming increasingly important, she stresses that medical professionals should discusses treatment options with patients. Holland says that being sensitive to patient needs is key in cancer treatment.